N4 Pharma(GB:THAT)
GBX 0.580.00 (0.00%)
GB:THAT
N4 Pharma financials statements
GBX 0.58
At close:0.00 (0.00%)
Want to see GB:THAT full AI Analyst Report?
N4 Pharma (THAT) Income Statement
7 Followers
N4 Pharma Income Statement
Last quarter (Q2 2026), N4 Pharma's total revenue was £3.64K, an increase of 86.48% from the same quarter last year. In Q2, N4 Pharma's net income was £-754.93K. See N4 Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 7.26K | £ 7.28K | £ 1.95K | £ 0.00 | £ 0.00 | |
| £ 7.26K | £ 7.28K | £ 1.95K | £ 0.00 | £ 0.00 | |
| £ 1.11M | £ 1.17M | £ 1.43M | £ 1.19M | £ 1.84M | |
| Depreciation and Amortization | £ 0.00 | £ 0.00 | £ 89.17K | £ 228.49K | £ 236.56K |
| £ -1.10M | £ -1.22M | £ -1.33M | £ -1.19M | £ -1.84M | |
| £ -1.10M | £ -1.22M | £ -1.43M | £ -1.19M | £ -1.84M | |
| £ 61.13K | £ -61.21K | £ 0.00 | £ 0.00 | £ 677.00 | |
| £ -1.10M | £ -1.22M | £ -1.43M | £ -1.19M | £ -1.84M | |
| £ -1.21M | £ -1.06M | £ -1.27M | £ -1.03M | £ -1.54M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.00 | £ -0.00 | £ -0.01 | £ -0.01 | £ -0.01 |
| Diluted EPS | £ -0.00 | £ -0.00 | £ -0.01 | £ -0.01 | £ -0.01 |
| Weighted Average Shares Outstanding | 724.40M | 340.39M | 242.89M | 186.42M | 181.08M |
| Weighted Average Shares Outstanding (Diluted) | 724.40M | 340.88M | 242.89M | 186.42M | 181.08M |
Currency in GBP
